mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TTN
Gene summary
Basic gene Info.Gene symbolTTN
Gene nametitin
SynonymsCMD1G|CMH9|CMPD4|EOMFC|HMERF|LGMD2J|MYLK5|TMD
CytomapUCSC genome browser: 2q31
Type of geneprotein-coding
RefGenesNM_001256850.1,
NM_001267550.2,NM_003319.4,NM_133378.4,NM_133379.4,
NM_133432.3,NM_133437.4,
Descriptionconnectinrhabdomyosarcoma antigen MU-RMS-40.14
Modification date20141222
dbXrefs MIM : 188840
HGNC : HGNC
Ensembl : ENSG00000155657
HPRD : 01787
Vega : OTTHUMG00000154448
ProteinUniProt: Q8WZ42
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TTN
BioGPS: 7273
PathwayNCI Pathway Interaction Database: TTN
KEGG: TTN
REACTOME: TTN
Pathway Commons: TTN
ContextiHOP: TTN
ligand binding site mutation search in PubMed: TTN
UCL Cancer Institute: TTN
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0051592response to calcium ion7607248


Top
Ligand binding site mutations for TTN

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
V2954T2952ICOAD2
T2945D2947NCOAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TTN
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
T2945D2947N-1.0899177
V2954T2952I-0.29957278
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TTN from PDB
PDB IDPDB titlePDB structure
1BPVTITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE, NMR, 50 STRUCTURES

Top
Differential gene expression and gene-gene network for TTN
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TTN and the right PPI network was created from samples without mutations in the LBS of TTN. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TTN
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0007193Cardiomyopathy, Dilated28AlteredExpression, Biomarker, GeneticVariation
umls:C0026848Muscular Diseases10Biomarker, GeneticVariation
umls:C1863599Hereditary Myopathy with Early Respiratory Failure9Biomarker, GeneticVariation
umls:C1838244TIBIAL MUSCULAR DYSTROPHY, TARDIVE7Biomarker, GeneticVariation
umls:C0751336Distal Myopathies5Biomarker, GeneticVariation
umls:C0340427Familial dilated cardiomyopathy4Biomarker
umls:C1861065Cardiomyopathy, Familial Hypertrophic, 92Biomarker, GeneticVariation
umls:C2673677Myopathy, Early-Onset, with Fatal Cardiomyopathy1Biomarker, GeneticVariation
umls:C0151786Muscle Weakness1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TTN
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TTN go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of TTN
Multiple alignments for Q8WZ42 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas